AMAbdelmalek Mouazer

Abdelmalek Mouazer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abdelmalek Mouazer has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management

    by Abdelmalek Mouazer, Sophie Dubois, Romain Léguillon, Nada Boudegzdame, Thibaud Levrard, Yoann Le Bars, Christian Simon, Brigitte Séroussi, Julien Grosjean, Romain Lelong, et al.

    Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines and on the visual presentation of aggregated drug knowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial, each pharmacist performing a medication review for two fictitious patients without ABiMed, and two others with ABiMed. We recorded the problems identified by the pharmacists, the interventions proposed, the response time, the perceived usability and the comments. Pharmacists' medication reviews were compared to an expert-designed gold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant drug-related problems during the medication review (p=1.1e-12) and proposed better interventions (p=9.8e-9), without needing more time (p=0.56). The System Usability Scale score is 82.7, which is ranked "excellent". In their comments, pharmacists appreciated the visual aspect of ABiMed and its ability to compare the current treatment with the proposed one. A multifactor analysis showed no difference in the support offered by ABiMed according to the pharmacist's age or sex, in terms of percentage of problems identified or quality of the proposed interventions. Conclusions: The use of an intelligent and visual clinical decision support system can help pharmacists when they perform medication reviews. Our main perspective is the validation of the system in clinical conditions.

  • Open Access

    Adaptive questionnaires for facilitating patient data entry in clinical decision support systems: Methods and application to STOPP/START v2

    by Jean-Baptiste Lamy, Abdelmalek Mouazer, Karima Sedki, Sophie Dubois, Hector Falcoff

    Clinical decision support systems are software tools that help clinicians to make medical decisions. However, their acceptance by clinicians is usually rather low. A known problem is that they often require clinicians to manually enter lots of patient data, which is long and tedious. Existing solutions, such as the automatic data extraction from electronic health record, are not fully satisfying, because of low data quality and availability. In practice, many systems still include long questionnaire for data entry. In this paper, we propose an original solution to simplify patient data entry, using an adaptive questionnaire, i.e. a questionnaire that evolves during user interaction, showing or hiding questions dynamically. Considering a rule-based decision support systems, we designed methods for translating the system's clinical rules into display rules that determine the items to show in the questionnaire, and methods for determining the optimal order of priority among the items in the questionnaire. We applied this approach to a decision support system implementing STOPP/START v2, a guideline for managing polypharmacy. We show that it permits reducing by about two thirds the number of clinical conditions displayed in the questionnaire. Presented to clinicians during focus group sessions, the adaptive questionnaire was found "pretty easy to use". In the future, this approach could be applied to other guidelines, and adapted for data entry by patients.

  • Open Access

    Model and Strategy for Predicting and Discovering Drug-Drug Interactions

    by Abdelmalek Mouazer, Nada Boudegzdame, Karima Sedki, Rosy Tsopra, Jean-Baptiste Lamy

    Taking several medications at the same time is an increasingly common phenomenon in our society. The combination of drugs is certainly not without risk of potentially dangerous interactions. Taking into account all possible interactions is a very complex task as it is not yet known what all possible interactions between drugs and their types are. Machine learning based models have been developed to help with this task. However, the output of these models is not structured enough to be integrated in a clinical reasoning process on interactions. In this work, we propose a clinically relevant and technically feasible model and strategy for drug interactions.


  • Open Access

    Decision-support systems for managing polypharmacy in the elderly: A scoping review

    by Abdelmalek Mouazer, Rosy Tsopra, Karima Sedki, Catherine Letord, Jean-Baptiste Lamy


  • Open Access

    Visualization of Drug Interactions for Supporting Medication Review

    by Mouazer Abdelmalek, Sedki Karima, Tsopra Rosy, Lamy Jean-Baptiste

    The number of elderly patients with multimorbidities has considerably increased since recent years. These patients are often polymedicated and at higher risk of safety incidents due to polypharmacy. To reduce polypharmacy, one solution is Medication review (MR). MR aimed at optimizing drug treatments, is unfortunately not very frequent in practice. Indeed, consulting the properties of 5-20 drugs in parallel is a cognitively complex task. It is therefore necessary to develop software for supporting MR. The existing tools only list alerts concerning drugs and their interactions. The objective of our work is to facilitate the pharmacist's access to the medical knowledge necessary for drug interactions. Using visual analytics, we propose an interactive tool that synthesizes information on drug interactions. It shows an overview of drug treatment and make it visually accessible by the pharmacist to facilitate MR.